Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of nonalcoholic fatty liver disease in non‐obese populations: Meta‐analytic assessment of its prevalence, genetic, metabolic, and histological profiles
Ziyuan Zou, Vincent Wai‐Sun Wong, Jian‐Gao Fan
Journal of Digestive Diseases (2020) Vol. 21, Iss. 7, pp. 372-384
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Mohammad Shafi Kuchay, José Ignacio Martínez‐Montoro, Narendra S. Choudhary, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1346-1346
Open Access | Times Cited: 72
A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 36, Iss. 6, pp. 1497-1507
Open Access | Times Cited: 70
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study
Mahmud Mahamid, Wiliam Nseir, Tawfik Khoury, et al.
European Journal of Gastroenterology & Hepatology (2020) Vol. 33, Iss. 12, pp. 1578-1581
Open Access | Times Cited: 70
Association of genetic variations with NAFLD in lean individuals
Huapeng Lin, Grace Lai‐Hung Wong, Carl Whatling, et al.
Liver International (2021) Vol. 42, Iss. 1, pp. 149-160
Closed Access | Times Cited: 61
Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Jane Ha, Sun Young Yim, Raffi Karagozian
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 10, pp. 2496-2507.e5
Open Access | Times Cited: 45
Gastrointestinal cancers in lean individuals with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Matheus Souza, Ivanna Diaz, Ilaria Barchetta, et al.
Liver International (2023) Vol. 44, Iss. 1, pp. 6-14
Open Access | Times Cited: 27
Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis
Wasit Wongtrakul, Natthinee Charatcharoenwitthaya, Phunchai Charatcharoenwitthaya
Annals of Hepatology (2024) Vol. 29, Iss. 3, pp. 101288-101288
Open Access | Times Cited: 10
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
Shang‐Chin Huang, Hau-Jyun Su, Jia‐Horng Kao, et al.
Gut and Liver (2021) Vol. 15, Iss. 3, pp. 451-458
Open Access | Times Cited: 52
Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics
Nan Tang, Lei Ji, Xinyu Shi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 502-502
Open Access | Times Cited: 6
Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD)
Yu Lan, Ran Song, Duiping Feng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives
Diego García‐Compeán, Emanuela Orsi, Ramesh Kumar, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 8, pp. 775-793
Open Access | Times Cited: 26
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
Aamir Bashir, Ajay Duseja, Arka De, et al.
Liver Research (2022) Vol. 6, Iss. 2, pp. 72-83
Open Access | Times Cited: 23
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Ankoor Patel, Dhiraj Peddu, Sahil Amin, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 22
Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns
Fanhong Zeng, Yue Zhang, Xu Han, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 30
Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Non-Obese Patients with Schizophrenia: A Retrospective Study
Wenying Yi, Haibo Wu, Weibin Fu, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 841-849
Open Access | Times Cited: 3
Mechanisms of nonalcoholic fatty liver disease and implications for surgery
Benedikt Kaufmann, Agustina Reca, Baocai Wang, et al.
Langenbeck s Archives of Surgery (2020) Vol. 406, Iss. 1, pp. 1-17
Open Access | Times Cited: 30
Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals
Huajie Dai, Jiali Xiang, Yanan Hou, et al.
Nutrition & Metabolism (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Assessing the longitudinal association between the GGT/HDL-C ratio and NAFLD: a cohort study in a non-obese Chinese population
Qiyang Xie, Song Lu, Maobin Kuang, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Chia‐Yen Dai, Tzu‐Jung Fang, Wei‐Wen Hung, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1487-1487
Open Access | Times Cited: 14
Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study
Fangyuan Cong, Luying Zhu, Lihua Deng, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
The role of TRIM family in metabolic associated fatty liver disease
Jingyue Zhang, Ying‐Ming Zhang, Ze Ren, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
TET2 regulation of alcoholic fatty liver via Srebp1 mRNA in paraspeckles
Li Zhao, Yanyan Pan, Jing Zhang, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109278-109278
Open Access | Times Cited: 2
The effects of pomegranate (Punica granatum) on nonalcoholic fatty liver disease: A systematic review of in vivo interventional studies
Hadith Tangestani, Ali Jamshidi, Akram Farhadi, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4189-4201
Closed Access | Times Cited: 2
Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood
Jasmin de Groot, Susana Santos, Madelon L. Geurtsen, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102248-102248
Open Access | Times Cited: 6
Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease
Tanya Ralli, Yub Raj Neupane, Zoya Saifi, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 46, pp. 4677-4685
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top